Related Experiment Video

Updated: Mar 7, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K

Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?

Elisa Greggio1, Luigi Bubacco2, Isabella Russo2

  • 1Department of Biology, University of Padova, Via Ugo Bassi 58/B, Padova 35121, Italy elisa.greggio@unipd.it isabella.russo@unipd.it.

Biochemical Society Transactions
|February 17, 2017
PubMed

Insights

Leucine-rich repeat kinase 2 (LRRK2) and Protein Kinase A (PKA) signaling are vital in brain function and Parkinson's disease (PD). This review explores their interconnected roles in neurons and microglia.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) regulates neuronal and glial cell functions.
  • Mutations in LRRK2 are the most common cause of autosomal dominant Parkinson's disease (PD).
  • Protein Kinase A (PKA) signaling is crucial for brain homeostasis, neuronal development, and inflammation control.

Purpose of the Study:

  • To review the evidence linking PKA and LRRK2 in neuronal and microglial functions.
  • To provide an overview of the cross-talk between PKA and LRRK2.
  • To discuss the molecular and cellular implications of this interaction.

Main Methods:

  • Literature review of existing research on LRRK2 and PKA signaling.
  • Analysis of studies investigating the roles of LRRK2 and PKA in neurodegeneration.
  • Synthesis of findings on the interplay between these kinases.

Main Results:

  • LRRK2 and PKA signaling pathways are implicated in neuron and microglia functions.
  • Dysregulation of LRRK2 is linked to Parkinson's disease.
  • Declining PKA signaling contributes to neurodegenerative disease progression.

Conclusions:

  • There is accumulating evidence for a link between PKA and LRRK2 in brain cells.
  • The cross-talk between PKA and LRRK2 has significant molecular and cellular implications for brain function and disease.
  • Further research is needed to fully elucidate the complex interactions between these kinases in health and Parkinson's disease.
Keywords:
LRRK2PKAParkinson's diseasemicroglianeuroinflammationneuron

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.5K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

16.2K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K